The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

Share Price Information for Walker Crips (WCW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.50
Bid: 22.00
Ask: 23.00
Change: 0.00 (0.00%)
Spread: 1.00 (4.545%)
Open: 22.50
High: 22.50
Low: 22.00
Prev. Close: 22.50
WCW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Total Voting Rights

12 May 2017 07:00

RNS Number : 9079E
Walker Crips Group plc
12 May 2017
 

12 May 2017

Walker Crips Group plc

Issue of Equity and Total Voting Rights

 

Further to its announcement of 9 March 2015 regarding the acquisition of Barker Poland Asset Management LLP ("BPAM"), Walker Crips Group plc ("Walker Crips" or the "Company"), the financial services group with activities including stockbroking, investment and wealth management, announces that an aggregate of 173,161 new ordinary shares in the capital of Company (the "BPAM Shares") have been issued and allotted to the Sellers of BPAM in order to satisfy the Company's obligations in connection with the payment of the year two BPAM deferred consideration. The BPAM business has met the targets required to trigger a payment by the Company of the full amount of the 2nd of 3 potential payments of deferred consideration.

Under the terms of the agreement for the acquisition of BPAM, deferred consideration may become due in each of the first three years following completion, dependent on the results achieved by the legacy BPAM Business. All deferred consideration due under the agreement is payable 90% in cash and 10% in new ordinary shares in the Company. The cash element of the year two deferred consideration has been satisfied from the Company's existing cash resources.

In addition, a further 178,574 new ordinary shares (the "Additional Shares" and, together with the BPAM Shares, the "Shares") have been issued and allotted to personnel associated with the Company in order to meet contractual commitments made by the Company as part of the ongoing recruitment of investment advisers and expansion of its client base. It has been agreed that the onward sale of these Additional Shares will be restricted for the period until 21 March 2021 at the earliest.

Application is being made to the UK Listing Authority for the Shares (which, in aggregate, amount to 351,735 Shares) to be admitted to the Official List, and application is being made to the London Stock Exchange for the Shares to be admitted to trading on its main market for listed securities. It is expected that such admission will become effective at 8.00 am on 16 May 2017 ("Admission").

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company notifies the market that following Admission, the Company's issued share capital will consist of 42,738,158 ordinary shares with a nominal value of 6 2/3 pence each ("Ordinary Shares") with each Ordinary Share carrying the right to one vote. The Company holds 750,000 Ordinary Shares in Treasury. Therefore, following Admission, the Company will have 41,988,158 Ordinary Shares in issue (excluding treasury shares) and, accordingly, the total number of voting rights in the Company will be 41,988,158.

The above figure 41,988,158 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Walker Crips Group plc under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information contact:

Walker Crips Group plc +44 (0) 20 3100 8000

Rodney FitzGerald, Chief Executive

Cantor Fitzgerald Europe   +44 (0) 20 7894 7667

Rishi Zaveri

Forward-Looking Statements

This Announcement contains (or may contain) certain forward-looking statements with respect to certain of the Company's current expectations and projections about future events. These statements, which sometimes use words such has "aim, "anticipate", "believe", "intend", "plan", "estimate", "expect" and words of a similar meaning, reflect the directors' beliefs and expectations and involve a number of risks, uncertainties and assumptions that could cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statement. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Statements contained in this Announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The information contained in this Announcement is subject to change without notice and, except as required by applicable law, neither the Company, nor any member of its group, its Directors or its Financial Adviser assumes any responsibility or obligation to update publicly or review any of the forward-looking statements contained therein. Investors should not place undue reliance on forward-looking statements, which speak only as of the date of this Announcement. No statement in this Announcement is or is intended to be a profit forecast or to imply that the earnings of the Company for the current or future financial years will necessarily match or exceed the historical or published earnings of the Company.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMGMKFMGGNZM
Date   Source Headline
28th Dec 202312:15 pmRNSResults for the six months ended 30 September 2023
27th Sep 20232:07 pmRNSResult of AGM
31st Jul 20236:25 pmRNSFinal results for the year ended 31 March 2023
23rd Dec 202210:00 amRNSHalf-year Report
11th Oct 20225:19 pmRNSDirector/PDMR Shareholding
29th Sep 20221:37 pmRNSResult of AGM
29th Jul 20223:01 pmRNSFinal Results
9th Jun 20223:28 pmRNSHolding(s) in Company
26th Apr 20222:17 pmRNSDirector/PDMR Shareholding
29th Mar 20223:25 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSHalf-year Report
28th Sep 20211:12 pmRNSResult of AGM
16th Sep 20219:06 amRNSSecond Price Monitoring Extn
16th Sep 20219:00 amRNSPrice Monitoring Extension
20th Aug 20213:40 pmRNSFinal Results
28th Jan 20215:39 pmRNSDirector/PDMR Shareholding
27th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 202112:03 pmRNSDirector/PDMR Shareholding
22nd Dec 20203:00 pmRNSExternal Auditor Appointment
27th Nov 20209:34 amRNSHalf-year Report - Replacement
27th Nov 20207:00 amRNSHalf-year Report
28th Oct 20209:24 amRNSDirector/PDMR Shareholding
2nd Oct 20203:55 pmRNSDirector/PDMR Shareholding
28th Sep 20207:00 amRNSDirector/PDMR Shareholding
18th Sep 20205:57 pmRNSDirector/PDMR Shareholding - Replacement
18th Sep 20204:48 pmRNSDirector/PDMR Shareholding
11th Sep 202010:01 amRNSDirector/PDMR Shareholding
9th Sep 202012:30 pmRNSResult of AGM
19th Aug 202012:25 pmRNSDirector/PDMR Shareholding
4th Aug 20202:59 pmRNSDirector/PDMR Shareholding
31st Jul 20204:00 pmRNSAppointment of Broker
31st Jul 20203:47 pmRNSFinal Results
15th Jun 20207:00 amRNSDirector/PDMR Shareholding
24th Dec 201911:15 amRNSDirector/PDMR Shareholding
27th Nov 20197:00 amRNSHalf-year Report
26th Nov 201912:55 pmRNSDirector/PDMR Shareholding
13th Nov 20193:05 pmRNSDirector/PDMR Shareholding
3rd Oct 201912:12 pmRNSDirector/PDMR Shareholding
2nd Oct 20192:05 pmRNSSecond Price Monitoring Extn
2nd Oct 20192:00 pmRNSPrice Monitoring Extension
24th Sep 20197:00 amRNSManagement Changes
23rd Sep 20194:30 pmRNSDirector/PDMR Shareholding
4th Sep 20193:00 pmRNSResult of AGM
4th Sep 20198:30 amRNSBoard Changes
22nd Aug 20199:30 amRNSDirector/PDMR Shareholding
31st Jul 20195:19 pmRNSDirector/PDMR Shareholding
31st Jul 201910:20 amRNSDirector/PDMR Shareholding
29th Jul 20192:40 pmRNSDirector/PDMR Shareholding
11th Jul 201912:03 pmRNSFinal Results
27th Jun 20195:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.